The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Immunotherapeutic Implications of Il-6 Blockade for Cytokine Storm
Abstract
IL-6 contributes to host defense against infections and tissue injuries. However, exaggerated, excessive synthesis of IL-6 while fighting environmental stress leads to an acute severe systemic inflammatory response known as 'cytokine storm', since high levels of IL-6 can activate the coagulation pathway and vascular endothelial cells but inhibit myocardial function. Remarkable beneficial effects of IL-6 blockade therapy using a humanized anti-IL-6 receptor antibody, tocilizumab were recently observed in patients with cytokine release syndrome complicated by T-cell engaged therapy. In this review we propose the possibility that IL-6 blockade may constitute a novel therapeutic strategy for other types of cytokine storm, such as the systemic inflammatory response syndrome including sepsis, macrophage activation syndrome and hemophagocytic lymphohistiocytosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angus, D. C., Linde-Zwirble, W. T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, M. R. (2001) · Critical Care Medicine · doi:10.1097/00003246-200107000-00002 · Cited by 8,503
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
IL‐6 in inflammation, immunity, and disease
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016295 · Cited by 5,046
Self-citationSevere Sepsis and Septic Shock
Angus, D. C., & van der Poll, T. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208623 · Cited by 3,961
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Grupp, S. A., Kalos, M., Barrett, D., Aplenc, R., Porter, D. L., Rheingold, S. R., Teachey, D. T., Chew, A., Hauck, B., Wright, J. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215134 · Cited by 3,509
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
Conference, F. T. I. S. D., Levy, M. M., Fink, M. P., Marshall, J. C., Abraham, E., Angus, D., Cook, D., Cohen, J., Opal, S. M., Vincent, J.-L., et al. (2003) · Intensive Care Medicine · doi:10.1007/s00134-003-1662-x · Cited by 2,871
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
Hotchkiss, R. S., Monneret, G., & Payen, D. (2013) · Nature Reviews Immunology · doi:10.1038/nri3552 · Cited by 2,772
Interleukin-6 and the acute phase response
Heinrich, P. C., Castell, J. V., & Andus, T. (1990) · Biochemical Journal · doi:10.1042/bj2650621 · Cited by 2,734
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,476
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Kishimoto, T. (1989) · Blood · doi:10.1182/blood.v74.1.1.1 · Cited by 2,069
Self-citationDisseminated Intravascular Coagulation
Levi, M., & ten Cate, H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410807 · Cited by 2,005
Negative Inotropic Effects of Cytokines on the Heart Mediated by Nitric Oxide
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992) · Science · doi:10.1126/science.1631560 · Cited by 1,628
IL‐6: Regulator of Treg/Th17 balance
Kimura, A., & Kishimoto, T. (2010) · European Journal of Immunology · doi:10.1002/eji.201040391 · Cited by 1,595
Self-citationXing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., & Achong, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1368 · Cited by 1,498
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Self-citationInterleukin-6 in Biology and Medicine
Akira, S., Taga, T., & Kishimoto, T. (1993) · Advances in Immunology · doi:10.1016/s0065-2776(08)60532-5 · Cited by 1,389
Self-citationImai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356
MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
Gerszten, R. E., Garcia-Zepeda, E. A., Lim, Y.-C., Yoshida, M., Ding, H. A., Gimbrone, M. A., Luster, A. D., Luscinskas, F. W., & Rosenzweig, A. (1999) · Nature · doi:10.1038/19546 · Cited by 1,244
Waage, A., Brandtzaeg, P., Halstensen, A., Kierulf, P., & Espevik, T. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.1.333 · Cited by 1,173
Role of IL-6 and Its Soluble Receptor in Induction of Chemokines and Leukocyte Recruitment
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P., Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997) · Immunity · doi:10.1016/s1074-7613(00)80334-9 · Cited by 1,112
Interleukin 6 Induces the Expression of Vascular Endothelial Growth Factor
Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G., & Levi, B.-Z. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.736 · Cited by 1,039
INTERLEUKIN-6: From Basic Science to Medicine—40 Years in Immunology
Kishimoto, T. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115806 · Cited by 1,024
Self-citationGeneration of C5a in the absence of C3: a new complement activation pathway
Huber-Lang, M., Sarma, J. V., Zetoune, F. S., Rittirsch, D., Neff, T. A., McGuire, S. R., Lambris, J. D., Warner, R. L., Flierl, M. A., Hoesel, L. M., et al. (2006) · Nature Medicine · doi:10.1038/nm1419 · Cited by 975
DAMPening Inflammation by Modulating TLR Signalling
Piccinini, A. M., & Midwood, K. S. (2010) · Mediators of Inflammation · doi:10.1155/2010/672395 · Cited by 973
Liver: An organ with predominant innate immunity
Gao, B., Jeong, W.-I., & Tian, Z. (2008) · Hepatology · doi:10.1002/hep.22034 · Cited by 952
Shakoory, B., Carcillo, J. A., Chatham, W. W., Amdur, R. L., Zhao, H., Dinarello, C. A., Cron, R. Q., & Opal, S. M. (2016) · Critical Care Medicine · doi:10.1097/ccm.0000000000001402 · Cited by 867
Opal, S. M., Fisher, C. J., Dhainaut, J.-F. A., Vincent, J.-L., Brase, R., Lowry, S. F., Sadoff, J. C., Slotman, G. J., Levy, H., Balk, R. A., et al. (1997) · Critical Care Medicine · doi:10.1097/00003246-199707000-00010 · Cited by 865
The systemic immune response to trauma: an overview of pathophysiology and treatment
Lord, J. M., Midwinter, M. J., Chen, Y.-F., Belli, A., Brohi, K., Kovacs, E. J., Koenderman, L., Kubes, P., & Lilford, R. J. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60687-5 · Cited by 846
Increased plasma levels of interleukin-6 in sepsis [see comments]
Hack, C., De Groot, E., Felt-Bersma, R., Nuijens, J., Strack Van Schijndel, R., Eerenberg-Belmer, A., Thijs, L., & Aarden, L. (1989) · Blood · doi:10.1182/blood.v74.5.1704.1704 · Cited by 811
Cytokine Serum Level During Severe Sepsis in Human IL-6 as a Marker of Severity
DAMA, P., LEDOUX, D., NYS, M., VRINDTS, Y., GROOTE, D. D., FRANCHIMONT, P., & LAMY, M. (1992) · Annals of Surgery · doi:10.1097/00000658-199204000-00009 · Cited by 808
Yokota, S., Imagawa, T., Mori, M., Miyamae, T., Aihara, Y., Takei, S., Iwata, N., Umebayashi, H., Murata, T., Miyoshi, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60454-7 · Cited by 789
Self-citationRandomized trial of tocilizumab in systemic juvenile idiopathic arthritis
De Benedetti, F., Brunner, H. I., Ruperto, N., Kenwright, A., Wright, S., Calvo, I., Cuttica, R., Ravelli, A., Schneider, R., Woo, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1112802 · Cited by 763
Managing Cytokine Release Syndrome Associated With Novel T Cell-Engaging Therapies
Maude, S. L., Barrett, D., Teachey, D. T., & Grupp, S. A. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000035 · Cited by 752
Cytokines in Sepsis: Potent Immunoregulators and Potential Therapeutic Targets—An Updated View
Schulte, W., Bernhagen, J., & Bucala, R. (2013) · Mediators of Inflammation · doi:10.1155/2013/165974 · Cited by 745
Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis
Bozza, F. A., Salluh, J. I., Japiassu, A. M., Soares, M., Assis, E. F., Gomes, R. N., Bozza, M. T., Castro-Faria-Neto, H. C., & Bozza, P. T. (2007) · Critical Care · doi:10.1186/cc5783 · Cited by 740
Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells
Esser, S., Lampugnani, M. G., Corada, M., Dejana, E., & Risau, W. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.13.1853 · Cited by 715
Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling
Jones, S. A., Scheller, J., & Rose-John, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57158 · Cited by 683
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis
Kaser, A., Brandacher, G., Steurer, W., Kaser, S., Offner, F. A., Zoller, H., Theurl, I., Widder, W., Molnar, C., Ludwiczek, O., et al. (2001) · Blood · doi:10.1182/blood.v98.9.2720 · Cited by 667
Interleukin-6 and its receptor: a paradigm for cytokines
Kishimoto, T., Akira, S., & Taga, T. (1992) · Science · doi:10.1126/science.1411569 · Cited by 665
Self-citationSepsis-induced immune dysfunction: can immune therapies reduce mortality?
Delano, M. J., & Ward, P. A. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82224 · Cited by 644
Teachey, D. T., Rheingold, S. R., Maude, S. L., Zugmaier, G., Barrett, D. M., Seif, A. E., Nichols, K. E., Suppa, E. K., Kalos, M., Berg, R. A., et al. (2013) · Blood · doi:10.1182/blood-2013-02-485623 · Cited by 613
The origins, function, and regulation of T follicular helper cells
Ma, C. S., Deenick, E. K., Batten, M., & Tangye, S. G. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120994 · Cited by 552
Heat stroke: Role of the systemic inflammatory response
Leon, L. R., & Helwig, B. G. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00301.2010 · Cited by 512
Interleukin-6: Biology, signaling and strategies of blockade
Schaper, F., & Rose-John, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.07.004 · Cited by 509
Interleukin-6 in the Injured Patient: Marker of Injury or Mediator of Inflammation?
Biffl, W. L., Moore, E. E., Moore, F. A., & Peterson, V. M. (1996) · Annals of Surgery · doi:10.1097/00000658-199611000-00009 · Cited by 502
Jirik, F. R., Podor, T. J., Hirano, T., Kishimoto, T., Loskutoff, D. J., Carson, D. A., & Lotz, M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.1.144 · Cited by 459
Self-citationPathogenesis of Macrophage Activation Syndrome and Potential for Cytokine- Directed Therapies
Schulert, G. S., & Grom, A. A. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-061813-012806 · Cited by 402
van der Poll, T., Levi, M., Hack, C. E., ten Cate, H., van Deventer, S. J., Eerenberg, A. J., de Groot, E. R., Jansen, J., Gallati, H., & Büller, H. R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1253 · Cited by 383
The Biology and Medical Implications of Interleukin-6
Tanaka, T., & Kishimoto, T. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0022 · Cited by 375
Self-citationRole of interleukin 6 in myocardial dysfunction of meningococcal septic shock
Pathan, N., Hemingway, C. A., Alizadeh, A. A., Stephens, A. C., Boldrick, J. C., Oragui, E. E., McCabe, C., Welch, S. B., Whitney, A., O'Gara, P., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(03)15326-3 · Cited by 362
Reinhart, K., Wiegand-Lohnert, C., Grimminger, F., Kaul, M., Withington, S., Treacher, D., Eckart, J., Willatts, S., Bouza, C., Krausch, D., et al. (1996) · Critical Care Medicine · doi:10.1097/00003246-199605000-00003 · Cited by 361
IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.
Okada, M., Kitahara, M., Kishimoto, S., Matsuda, T., Hirano, T., & Kishimoto, T. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.141.5.1543 · Cited by 359
Self-citationBerghe, W. V., De Bosscher, K., Boone, E., Plaisance, S., & Haegeman, G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32091 · Cited by 354
Chimeric Antigen Receptor Therapy for Cancer
Barrett, D. M., Singh, N., Porter, D. L., Grupp, S. A., & June, C. H. (2014) · Annual Review of Medicine · doi:10.1146/annurev-med-060512-150254 · Cited by 349
Narazaki, M., Yasukawa, K., Saito, T., Ohsugi, Y., Fukui, H., Koishihara, Y., Yancopoulos, G., Taga, T., & Kishimoto, T. (1993) · Blood · doi:10.1182/blood.v82.4.1120.1120 · Cited by 343
Self-citationProtective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression
Riedemann, N. C., Neff, T. A., Guo, R.-F., Bernacki, K. D., Laudes, I. J., Sarma, J. V., Lambris, J. D., & Ward, P. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.503 · Cited by 330
Current trends in inflammatory and immunomodulatory mediators in sepsis
Aziz, M., Jacob, A., Yang, W.-L., Matsuda, A., & Wang, P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0912437 · Cited by 309
Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity
Neumann, F.-J., Ott, I., Marx, N., Luther, T., Kenngott, S., Gawaz, M., Kotzsch, M., & Schömig, A. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.12.3399 · Cited by 308
Campbell, L., Chen, C., Bhagat, S. S., Parker, R. A., & Ostor, A. J. K. (2011) · Rheumatology · doi:10.1093/rheumatology/keq343 · Cited by 282
Interleukin-6 Stimulates Coagulation, not Fibrinolysis, in Humans
Stouthard, J. M. L., Levi, M., Hack, C. E., Veenhof, C. H. N., Romijn, H. A., Sauerwein, H. P., & Poll, T. V. D. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650653 · Cited by 279
Dienz, O., Rud, J. G., Eaton, S. M., Lanthier, P. A., Burg, E., Drew, A., Bunn, J., Suratt, B. T., Haynes, L., & Rincon, M. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.2 · Cited by 275
Cifaldi, L., Prencipe, G., Caiello, I., Bracaglia, C., Locatelli, F., De Benedetti, F., & Strippoli, R. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39295 · Cited by 267
Therapeutic Targeting of the Interleukin-6 Receptor
Tanaka, T., Narazaki, M., & Kishimoto, T. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134715 · Cited by 262
Self-citationACUTE PANCREATITIS: MODELS, MARKERS, AND MEDIATORS
Granger, J., & Remick, D. (2005) · Shock · doi:10.1097/01.shk.0000191413.94461.b0 · Cited by 260
ODA, S., HIRASAWA, H., SHIGA, H., NAKANISHI, K., MATSUDA, K., & NAKAMUA, M. (2005) · Cytokine · doi:10.1016/j.cyto.2004.10.010 · Cited by 253
Cytokine storm of graft-versus-host disease: a critical effector role for interleukin-1.
Ferrara, J. L., Abhyankar, S., & Gilliland, D. G. (1993) · PubMed · Cited by 249
Strategies to improve drug development for sepsis
Fink, M. P., & Warren, H. S. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4368 · Cited by 242
Interleukin-6 Causes Endothelial Barrier Dysfunction via the Protein Kinase C Pathway
Desai, T. R., Leeper, N. J., Hynes, K. L., & Gewertz, B. L. (2002) · Journal of Surgical Research · doi:10.1006/jsre.2002.6415 · Cited by 235
Multiplex cytokine profiling in patients with sepsis
MERA, S., TATULESCU, D., CISMARU, C., BONDOR, C., SLAVCOVICI, A., ZANC, V., CARSTINA, D., & OLTEAN, M. (2011) · APMIS · doi:10.1111/j.1600-0463.2010.02705.x · Cited by 231
Role of Interleukin-6 in Mortality from and Physiologic Response to Sepsis
Remick, D. G., Bolgos, G., Copeland, S., & Siddiqui, J. (2005) · Infection and Immunity · doi:10.1128/iai.73.5.2751-2757.2005 · Cited by 230
Diagnostic Accuracy of a Specific Cytokine Pattern in Hemophagocytic Lymphohistiocytosis in Children
Xu, X.-J., Tang, Y.-M., Song, H., Yang, S.-L., Xu, W.-Q., Zhao, N., Shi, S.-W., Shen, H.-P., Mao, J.-Q., Zhang, L.-Y., et al. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.11.046 · Cited by 225
Marin, V., Montero-Julian, F. A., Grès, S., Boulay, V., Bongrand, P., Farnarier, C., & Kaplanski, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.6.3435 · Cited by 204
Advances in understanding the pathogenesis of HLH
Usmani, G. N., Woda, B. A., & Newburger, P. E. (2013) · British Journal of Haematology · doi:10.1111/bjh.12293 · Cited by 202
IL-6 Trans-Signaling in Formation and Progression of Malignant Ascites in Ovarian Cancer
Lo, C.-W., Chen, M.-W., Hsiao, M., Wang, S., Chen, C.-A., Hsiao, S.-M., Chang, J.-S., Lai, T.-C., Rose-John, S., Kuo, M.-L., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1496 · Cited by 193
Expression and Function of C5a Receptor in Mouse Microvascular Endothelial Cells
Laudes, I. J., Chu, J. C., Huber-Lang, M., Guo, R.-F., Riedemann, N. C., Sarma, J. V., Mahdi, F., Murphy, H. S., Speyer, C., Lu, K. T., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5962 · Cited by 181
Interleukin 6 is a prognostic indicator of outcome in severe intra-abdominal sepsis
Patel, R. T., Deen, K. I., Youngs, D., Warwick, J., & Keighley, M. R. B. (1994) · Journal of British Surgery · doi:10.1002/bjs.1800810914 · Cited by 172
Therapeutic uses of anti-interleukin-6 receptor antibody
Kang, S., Tanaka, T., & Kishimoto, T. (2015) · International Immunology · doi:10.1093/intimm/dxu081 · Cited by 170
Self-citationBarkhausen, T., Tschernig, T., Rosenstiel, P., van Griensven, M., Vonberg, R.-P., Dorsch, M., Mueller-Heine, A., Chalaris, A., Scheller, J., Rose-John, S., et al. (2011) · Critical Care Medicine · doi:10.1097/ccm.0b013e318211ff56 · Cited by 169
A new era for the treatment of inflammatory autoimmune diseases by interleukin-6 blockade strategy
Tanaka, T., Narazaki, M., Ogata, A., & Kishimoto, T. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.009 · Cited by 164
Self-citationSerial cytokine levels in patients with severe sepsis
Wu, H.-P., Chen, C.-K., Chung, K., Tseng, J., Hua, C., Liu, Y., Chuang, D., & Yang, C.-H. (2009) · Inflammation Research · doi:10.1007/s00011-009-0003-0 · Cited by 129
Interleukin-6 in Sepsis and Capillary Leakage Syndrome
Krüttgen, A., & Rose‐John, S. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0062 · Cited by 120
Yokota, S., Itoh, Y., Morio, T., Origasa, H., Sumitomo, N., Tomobe, M., Tanaka, K., & Minota, S. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207818 · Cited by 108
Yokota, S., Itoh, Y., Morio, T., Sumitomo, N., Daimaru, K., & Minota, S. (2015) · The Journal of Rheumatology · doi:10.3899/jrheum.140288 · Cited by 103
Rega‐Kaun, G., Kaun, C., Demyanets, S., Pfaffenberger, S., Rychli, K., Hohensinner, P. J., Kastl, S., Speidl, W. S., Weiss, T. W., Breuss, J. M., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.143081 · Cited by 102
de Jonge, E., Friederich, P. W., Vlasuk, G. P., Rote, W. E., Vroom, M. B., Levi, M. M., & van der Poll, T. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.3.495-497.2003 · Cited by 99
Dahiya, P. (2009) · Frontiers in bioscience · doi:10.2741/3580 · Cited by 96
Goldman, J. L., Sammani, S., Kempf, C. L., Saadat, L., Letsiou, E., Wang, T., Moreno‐Vinasco, L., Rizzo, A. N., Fortman, J. D., & Garcia, J. G. N. (2014) · Pulmonary Circulation · doi:10.1086/675991 · Cited by 88
Interleukin 6 (IL-6) levels in the monitoring of surgical trauma
Maruszyński, M., & Pojda, Z. (1995) · Surgical Endoscopy · doi:10.1007/bf00768883 · Cited by 86
Bhargava, R., Janssen, W. J., Altmann, C. J., Andrés-Hernando, A., Okamura, K., Vandivier, R. W., Ahuja, N., & Faubel, S. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061405 · Cited by 84
Experimental Therapeutic Strategies for Severe Sepsis: Mediators and Mechanisms
Parrish, W. R., Gallowitsch‐Puerta, M., Czura, C. J., & Tracey, K. J. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1418.011 · Cited by 74
Fujiwara, H., Nishimoto, N., Hamano, Y., Asanuma, N., Miki, S., Kasayama, S., & Suemura, M. (2008) · Modern Rheumatology · doi:10.1007/s10165-008-0111-7 · Cited by 66
Ríos-Fernández, R., Callejas-Rubio, J. L., García‐Rodríguez, S., Sancho, J., Zubiaur, M., & Ortego‐Centeno, N. (2015) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000035 · Cited by 23
Yanagawa, Y., Hirano, Y., Kato, H., & Iba, T. (2012) · BMJ Case Reports · doi:10.1136/bcr.02.2012.5835 · Cited by 22
Faguer, S., Vergez, F., Pérès, M., Ferrandiz, I., Casemayou, A., Bellière, J., Cointault, O., Lavayssière, L., Nogier, M., Prévôt, G., et al. (2014) · Hematological Oncology · doi:10.1002/hon.2174 · Cited by 20
Advances in T-cell therapy for ALL
Grupp, S. A. (2014) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2014.10.014 · Cited by 18
Yamagata, K., Shimojo, N., Ito, H., Ijima, J., Hasegawa, S., Yanagawa, T., Mizutani, T., & Bukawa, H. (2014) · Case Reports in Dentistry · doi:10.1155/2014/649086 · Cited by 2
Cited by
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
Ye, Q., Wang, B., & Mao, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.037 · Cited by 2,761
Cytokine release syndrome in severe COVID-19
Moore, J. B., & June, C. H. (2020) · Science · doi:10.1126/science.abb8925 · Cited by 1,912
Shimabukuro-Vornhagen, A., Gödel, P., Subklewe, M., Stemmler, H. J., Schlößer, H. A., Schlaak, M., Kochanek, M., Böll, B., & von Bergwelt-Baildon, M. S. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0343-9 · Cited by 1,656
Immunology of COVID-19: Current State of the Science
Vabret, N., Britton, G. J., Gruber, C., Hegde, S., Kim, J., Kuksin, M., Levantovsky, R., Malle, L., Moreira, A., Park, M. D., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.05.002 · Cited by 1,623
Diabetes is a risk factor for the progression and prognosis of COVID‐19
Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., Qin, R., Wang, H., Shen, Y., Du, K., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3319 · Cited by 1,404
Metadata
- Authors
- Tanaka, T., Narazaki, M., & Kishimoto, T.
- Venue
- Immunotherapy
- Publisher
- Informa UK Limited
- Published
- 2016-07
- Volume
- 8
- Issue
- 8
- Pages
- 959-970
- ISSN
- 1750-743X (ISSN-L)
- 1750-7448
- OpenAlex
- W2471732223
- Cited by
- 708
- References
- 99
- FWCI
- 14.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.